Venture Partnerships & Investments

Financing, technology and domain know-how

Our Investment Focus

Our goals are to recognize potential, get involved early, limit threats and accept reasonable risks. The many assets Zühlke Ventures provide include sound financing, a wealth of management and technology experience, and our strong network.



Focus exclusively on early-stage investments in the HealthTech sector.


5 – 8 years


Main activity in Switzerland and Europe, complemented by interests in the US.


Zühlke Ventures hold a minority stake, with initial investments of CHF 150k – 250k per start-up.


Proactive, cooperative partnership gives start-up management access to Zühlke Group know-how.

Our Companies

Our Exits

Swisstom - Acquired by SenTec in 2018
Swisstom Partner
Message Automation - Acquired by Broadridge in 2017
Message Automation Partner
Lunaphore – Acquired by Bio-Techne in 2023
Logo of Lunaphore

Our Ventures Team

Contact us via email or phone: +41 43 216 6611

Patrick Griess Zuehlke Ventures

Patrick Griss

CEO & Partner


Dr. Patrick Griss is CEO of Zühlke Ventures, the investment arm of the Zühlke Group, and a board member of several disruptive companies. Using his experience as an operator in the HealthTech sector, he wears his Investor hat to identify top teams, business ideas and technologies, and lead them to success.

Stephan Wehrli Zuehlke Ventures

Stephan Wehrli



Stephan Wehrli is Investment Principal at Zühlke Ventures and a Partner in the Zühlke Group. Before he joined Zühlke Ventures, he worked for Zühlke Engineering as Business Unit Leader and Business Solution Manager, mainly for enterprise customers in the area of custom software development projects. Furthermore, he was responsible for the development of the Zühlke-offering “Rent a Startup” in Switzerland.

Let us get in touch with you